View in EDS PDF Full Text

Maintained anxiolytic effects of cannabidiol after treatment discontinuation in healthcare workers during the COVID-19 pandemic.

Saved in:
Bibliographic Details
Title: Maintained anxiolytic effects of cannabidiol after treatment discontinuation in healthcare workers during the COVID-19 pandemic.
Authors: Souza JDS; Department of Neuroscience and Behavior, Ribeirão Preto Medical School, University of São Paulo, Ribeirão Preto, Brazil., Zuardi AW; Department of Neuroscience and Behavior, Ribeirão Preto Medical School, University of São Paulo, Ribeirão Preto, Brazil.; National Institute for Science and Technology-Translational Medicine, Ribeirão Preto, Brazil., Guimarães FS; National Institute for Science and Technology-Translational Medicine, Ribeirão Preto, Brazil.; Department of Pharmacology, Ribeirão Preto Medical School, University of São Paulo, Ribeirão Preto, Brazil., Osório FL; Department of Neuroscience and Behavior, Ribeirão Preto Medical School, University of São Paulo, Ribeirão Preto, Brazil.; National Institute for Science and Technology-Translational Medicine, Ribeirão Preto, Brazil., Loureiro SR; Department of Neuroscience and Behavior, Ribeirão Preto Medical School, University of São Paulo, Ribeirão Preto, Brazil., Campos AC; Department of Pharmacology, Ribeirão Preto Medical School, University of São Paulo, Ribeirão Preto, Brazil., Hallak JEC; Department of Neuroscience and Behavior, Ribeirão Preto Medical School, University of São Paulo, Ribeirão Preto, Brazil.; National Institute for Science and Technology-Translational Medicine, Ribeirão Preto, Brazil., Dos Santos RG; Department of Neuroscience and Behavior, Ribeirão Preto Medical School, University of São Paulo, Ribeirão Preto, Brazil.; National Institute for Science and Technology-Translational Medicine, Ribeirão Preto, Brazil., Machado Silveira IL; Department of Neuroscience and Behavior, Ribeirão Preto Medical School, University of São Paulo, Ribeirão Preto, Brazil., Pereira-Lima K; University of Michigan Medical School, Ann Arbor, IN, United States.; Department of Psychiatry, Federal University of São Paulo, São Paulo, São Paulo, Brazil., Pacheco JC; Department of Neuroscience and Behavior, Ribeirão Preto Medical School, University of São Paulo, Ribeirão Preto, Brazil., Ushirohira JM; Department of Neuroscience and Behavior, Ribeirão Preto Medical School, University of São Paulo, Ribeirão Preto, Brazil., Ferreira RR; Department of Pharmacology, Ribeirão Preto Medical School, University of São Paulo, Ribeirão Preto, Brazil., Costa KCM; Department of Pharmacology, Ribeirão Preto Medical School, University of São Paulo, Ribeirão Preto, Brazil., Scomparin DS; Department of Pharmacology, Ribeirão Preto Medical School, University of São Paulo, Ribeirão Preto, Brazil., Scarante FF; Department of Pharmacology, Ribeirão Preto Medical School, University of São Paulo, Ribeirão Preto, Brazil., Pires-Dos-Santos I; Department of Pharmacology, Ribeirão Preto Medical School, University of São Paulo, Ribeirão Preto, Brazil., Mechoulam R; The Institute for Drug Research, School of Pharmacy, The Hebrew University of Jerusalem, Jerusalem, Israel., Kapczinski F; National Institute for Science and Technology-Translational Medicine, Ribeirão Preto, Brazil.; Department of Psychiatry and Behavioural Neurosciences, McMaster University and St. Joseph's Healthcare Hamilton, Hamilton, ON, Canada.; Department of Psychiatry, Faculty of Medicine, Graduate Program in Psychiatry and Behavioral Sciences, Universidade Federal do Rio Grande do Sul, Porto Alegre, Brazil., Fonseca BAL; Department of Internal Medicine, Ribeirão Preto Medical School, University of São Paulo, Ribeirão Preto, Brazil., Esposito DLA; Department of Internal Medicine, Ribeirão Preto Medical School, University of São Paulo, Ribeirão Preto, Brazil., Andraus MH; Chromatox Laboratory Ltd São Paulo, Brazil., Crippa JAS; Department of Neuroscience and Behavior, Ribeirão Preto Medical School, University of São Paulo, Ribeirão Preto, Brazil.; National Institute for Science and Technology-Translational Medicine, Ribeirão Preto, Brazil.
Source: Frontiers in pharmacology [Front Pharmacol] 2022 Oct 03; Vol. 13, pp. 856846. Date of Electronic Publication: 2022 Oct 03 (Print Publication: 2022).
Publication Type: Journal Article
Journal Info: Publisher: Frontiers Media] Country of Publication: Switzerland NLM ID: 101548923 Publication Model: eCollection Cited Medium: Print ISSN: 1663-9812 (Print) Linking ISSN: 16639812 NLM ISO Abbreviation: Front Pharmacol Subsets: PubMed not MEDLINE
Database: MEDLINE Ultimate
FullText Links:
  – Type: pdflink
Text:
  Availability: 0
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 36263136
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: Maintained anxiolytic effects of cannabidiol after treatment discontinuation in healthcare workers during the COVID-19 pandemic.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22Souza+JDS%22">Souza JDS</searchLink>; Department of Neuroscience and Behavior, Ribeirão Preto Medical School, University of São Paulo, Ribeirão Preto, Brazil.<br /><searchLink fieldCode="AU" term="%22Zuardi+AW%22">Zuardi AW</searchLink>; Department of Neuroscience and Behavior, Ribeirão Preto Medical School, University of São Paulo, Ribeirão Preto, Brazil.; National Institute for Science and Technology-Translational Medicine, Ribeirão Preto, Brazil.<br /><searchLink fieldCode="AU" term="%22Guimarães+FS%22">Guimarães FS</searchLink>; National Institute for Science and Technology-Translational Medicine, Ribeirão Preto, Brazil.; Department of Pharmacology, Ribeirão Preto Medical School, University of São Paulo, Ribeirão Preto, Brazil.<br /><searchLink fieldCode="AU" term="%22Osório+FL%22">Osório FL</searchLink>; Department of Neuroscience and Behavior, Ribeirão Preto Medical School, University of São Paulo, Ribeirão Preto, Brazil.; National Institute for Science and Technology-Translational Medicine, Ribeirão Preto, Brazil.<br /><searchLink fieldCode="AU" term="%22Loureiro+SR%22">Loureiro SR</searchLink>; Department of Neuroscience and Behavior, Ribeirão Preto Medical School, University of São Paulo, Ribeirão Preto, Brazil.<br /><searchLink fieldCode="AU" term="%22Campos+AC%22">Campos AC</searchLink>; Department of Pharmacology, Ribeirão Preto Medical School, University of São Paulo, Ribeirão Preto, Brazil.<br /><searchLink fieldCode="AU" term="%22Hallak+JEC%22">Hallak JEC</searchLink>; Department of Neuroscience and Behavior, Ribeirão Preto Medical School, University of São Paulo, Ribeirão Preto, Brazil.; National Institute for Science and Technology-Translational Medicine, Ribeirão Preto, Brazil.<br /><searchLink fieldCode="AU" term="%22Dos+Santos+RG%22">Dos Santos RG</searchLink>; Department of Neuroscience and Behavior, Ribeirão Preto Medical School, University of São Paulo, Ribeirão Preto, Brazil.; National Institute for Science and Technology-Translational Medicine, Ribeirão Preto, Brazil.<br /><searchLink fieldCode="AU" term="%22Machado+Silveira+IL%22">Machado Silveira IL</searchLink>; Department of Neuroscience and Behavior, Ribeirão Preto Medical School, University of São Paulo, Ribeirão Preto, Brazil.<br /><searchLink fieldCode="AU" term="%22Pereira-Lima+K%22">Pereira-Lima K</searchLink>; University of Michigan Medical School, Ann Arbor, IN, United States.; Department of Psychiatry, Federal University of São Paulo, São Paulo, São Paulo, Brazil.<br /><searchLink fieldCode="AU" term="%22Pacheco+JC%22">Pacheco JC</searchLink>; Department of Neuroscience and Behavior, Ribeirão Preto Medical School, University of São Paulo, Ribeirão Preto, Brazil.<br /><searchLink fieldCode="AU" term="%22Ushirohira+JM%22">Ushirohira JM</searchLink>; Department of Neuroscience and Behavior, Ribeirão Preto Medical School, University of São Paulo, Ribeirão Preto, Brazil.<br /><searchLink fieldCode="AU" term="%22Ferreira+RR%22">Ferreira RR</searchLink>; Department of Pharmacology, Ribeirão Preto Medical School, University of São Paulo, Ribeirão Preto, Brazil.<br /><searchLink fieldCode="AU" term="%22Costa+KCM%22">Costa KCM</searchLink>; Department of Pharmacology, Ribeirão Preto Medical School, University of São Paulo, Ribeirão Preto, Brazil.<br /><searchLink fieldCode="AU" term="%22Scomparin+DS%22">Scomparin DS</searchLink>; Department of Pharmacology, Ribeirão Preto Medical School, University of São Paulo, Ribeirão Preto, Brazil.<br /><searchLink fieldCode="AU" term="%22Scarante+FF%22">Scarante FF</searchLink>; Department of Pharmacology, Ribeirão Preto Medical School, University of São Paulo, Ribeirão Preto, Brazil.<br /><searchLink fieldCode="AU" term="%22Pires-Dos-Santos+I%22">Pires-Dos-Santos I</searchLink>; Department of Pharmacology, Ribeirão Preto Medical School, University of São Paulo, Ribeirão Preto, Brazil.<br /><searchLink fieldCode="AU" term="%22Mechoulam+R%22">Mechoulam R</searchLink>; The Institute for Drug Research, School of Pharmacy, The Hebrew University of Jerusalem, Jerusalem, Israel.<br /><searchLink fieldCode="AU" term="%22Kapczinski+F%22">Kapczinski F</searchLink>; National Institute for Science and Technology-Translational Medicine, Ribeirão Preto, Brazil.; Department of Psychiatry and Behavioural Neurosciences, McMaster University and St. Joseph's Healthcare Hamilton, Hamilton, ON, Canada.; Department of Psychiatry, Faculty of Medicine, Graduate Program in Psychiatry and Behavioral Sciences, Universidade Federal do Rio Grande do Sul, Porto Alegre, Brazil.<br /><searchLink fieldCode="AU" term="%22Fonseca+BAL%22">Fonseca BAL</searchLink>; Department of Internal Medicine, Ribeirão Preto Medical School, University of São Paulo, Ribeirão Preto, Brazil.<br /><searchLink fieldCode="AU" term="%22Esposito+DLA%22">Esposito DLA</searchLink>; Department of Internal Medicine, Ribeirão Preto Medical School, University of São Paulo, Ribeirão Preto, Brazil.<br /><searchLink fieldCode="AU" term="%22Andraus+MH%22">Andraus MH</searchLink>; Chromatox Laboratory Ltd São Paulo, Brazil.<br /><searchLink fieldCode="AU" term="%22Crippa+JAS%22">Crippa JAS</searchLink>; Department of Neuroscience and Behavior, Ribeirão Preto Medical School, University of São Paulo, Ribeirão Preto, Brazil.; National Institute for Science and Technology-Translational Medicine, Ribeirão Preto, Brazil.
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%22101548923%22">Frontiers in pharmacology</searchLink> [Front Pharmacol] 2022 Oct 03; Vol. 13, pp. 856846. <i>Date of Electronic Publication: </i>2022 Oct 03 (<i>Print Publication: </i>2022).
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Journal Article
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Frontiers+Media]%22">Frontiers Media] </searchLink><i>Country of Publication: </i>Switzerland <i>NLM ID: </i>101548923 <i>Publication Model: </i>eCollection <i>Cited Medium: </i>Print <i>ISSN: </i>1663-9812 (Print) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2216639812%22">16639812 </searchLink><i>NLM ISO Abbreviation: </i>Front Pharmacol <i>Subsets: </i>PubMed not MEDLINE
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=36263136
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.3389/fphar.2022.856846
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        StartPage: 856846
    Titles:
      – TitleFull: Maintained anxiolytic effects of cannabidiol after treatment discontinuation in healthcare workers during the COVID-19 pandemic.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Souza JDS
      – PersonEntity:
          Name:
            NameFull: Zuardi AW
      – PersonEntity:
          Name:
            NameFull: Guimarães FS
      – PersonEntity:
          Name:
            NameFull: Osório FL
      – PersonEntity:
          Name:
            NameFull: Loureiro SR
      – PersonEntity:
          Name:
            NameFull: Campos AC
      – PersonEntity:
          Name:
            NameFull: Hallak JEC
      – PersonEntity:
          Name:
            NameFull: Dos Santos RG
      – PersonEntity:
          Name:
            NameFull: Machado Silveira IL
      – PersonEntity:
          Name:
            NameFull: Pereira-Lima K
      – PersonEntity:
          Name:
            NameFull: Pacheco JC
      – PersonEntity:
          Name:
            NameFull: Ushirohira JM
      – PersonEntity:
          Name:
            NameFull: Ferreira RR
      – PersonEntity:
          Name:
            NameFull: Costa KCM
      – PersonEntity:
          Name:
            NameFull: Scomparin DS
      – PersonEntity:
          Name:
            NameFull: Scarante FF
      – PersonEntity:
          Name:
            NameFull: Pires-Dos-Santos I
      – PersonEntity:
          Name:
            NameFull: Mechoulam R
      – PersonEntity:
          Name:
            NameFull: Kapczinski F
      – PersonEntity:
          Name:
            NameFull: Fonseca BAL
      – PersonEntity:
          Name:
            NameFull: Esposito DLA
      – PersonEntity:
          Name:
            NameFull: Andraus MH
      – PersonEntity:
          Name:
            NameFull: Crippa JAS
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 03
              M: 10
              Text: 2022 Oct 03
              Type: published
              Y: 2022
          Identifiers:
            – Type: issn-print
              Value: 1663-9812
          Numbering:
            – Type: volume
              Value: 13
          Titles:
            – TitleFull: Frontiers in pharmacology
              Type: main
ResultId 1